JP2006517565A - 抗炎症剤のセチルピリジニウム塩及びそれを含有する薬学的組成物 - Google Patents
抗炎症剤のセチルピリジニウム塩及びそれを含有する薬学的組成物 Download PDFInfo
- Publication number
- JP2006517565A JP2006517565A JP2006501845A JP2006501845A JP2006517565A JP 2006517565 A JP2006517565 A JP 2006517565A JP 2006501845 A JP2006501845 A JP 2006501845A JP 2006501845 A JP2006501845 A JP 2006501845A JP 2006517565 A JP2006517565 A JP 2006517565A
- Authority
- JP
- Japan
- Prior art keywords
- diclofenac
- salt
- cetylpyridinium
- cetylpyridinium salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/18—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本発明は、抗炎症剤のセチルピリジニウム塩に、及びそれを含有する薬学的組成物に関する。
(式中、適切な溶媒中で、XはH又は無機の若しくは有機の陽イオンであり、及びYはOH又はハロゲンである。)に従ってジクロフェナクのセチルピリジニウム塩(I)を調製する工程、及びこのようにして得られる塩(I)を通常の技術によって分離する工程を含む方法に関する。
(ジクロフェナクのセチルピリジニウム塩の調製(方法A))
塩化セチルピリジニウム一水和物〔5.35g;14.94ミリモル(mmol)〕を水中(60mL)で60℃に予備加熱した溶液を、ジクロフェナクナトリウム(5.0g;15.72mmol)の水溶液(50mL)に、60℃でかき混ぜながら迅速に滴状に(dropwise)添加した。
(ジクロフェナクのセチルピリジニウム塩の調製(方法B))
ジクロフェナクナトリウム(3.18g;10mmol)及び塩化セチルピリジニウム(3.40g;10mmol)を、塩化メチレン(40mL)中、室温でかき混ぜながら、交換反作用が実質的に完了するまで(約30分)反応させた。
(局所的使用のためのゲル/懸濁物)
ジクロフェナクのセチルピリジニウム塩: 1.00g
精製水: 4.00g。
(洗口剤)
以下の組成を持つ溶液を慣習的な技術に従って調製した:
ジクロフェナクのセチルピリジニウム塩: 0.20g
キシリトール: 10.0g
安息香酸ナトリウム: 1.00g
天然の香味剤: 0.30g
着色剤 E114: 0.20g
精製水十分量(qs): 100g。
(薬用歯磨き)
以下の組成を持つ歯磨きを慣習的な技術に従って調製した:
ジクロフェナクのセチルピリジニウム塩: 0.10g
キシリトール: 5.00g
モノフルオロホウ酸ナトリウム: 0.15g
天然の香味剤: 0.45g
ラウリル硫酸ナトリウム: 0.10g
キサンタンガム: 10.0g
着色剤 E131: 0.20g
精製水qs: 100g。
(歯肉用ゲル)
以下の組成を持つゲルを慣習的な技術に従って調製した:
ジクロフェナクのセチルピリジニウム塩: 1.00g
KathomTM(ケーソン(商標)): 0.65g
EDTA二ナトリウム: 0.10g
ポリエトキシル化水素化ヒマシ油: 6.00g
PoloxamerTM(ポロキサマー(商標))407: 22.0g
ポリソルベート: 6.00g
塩化ナトリウム: 0.50g
滅菌精製水qs: 100g。
(直腸病学的ポマード)
以下の組成を持つポマードを慣習的な技術に従って調製した:
ジクロフェナクのセチルピリジニウム塩: 0.50g
ベンゾカイン: 1.00g
流動パラフィン: 3.00g
ポリエチレングリコール(混合物): 50.0g
白色ワセリン: 10.0g
プロピレングリコール: 10.0g
タルク: 5.00g
滅菌精製水qs: 100g。
Claims (11)
- 52〜55℃で融解することを特徴とする請求項1記載のジクロフェナクのセチルピリジニウム塩(I)。
- Xがアルカリ金属であることを特徴とする請求項3記載の方法。
- YがClであることを特徴とする請求項3記載の方法。
- 溶媒が水であることを特徴とする請求項3記載の方法。
- 溶媒が低分子量のハロ炭化水素であることを特徴とする請求項3記載の方法。
- ハロ炭化水素が1個から3個までの炭素原子を含むことを特徴とする請求項7記載の方法。
- ハロ炭化水素が、塩化メチレン、クロロホルム、四塩化炭素、ジクロロエタン、トリクロロエタン、テトラクロロエタン、トリクロロエチレン及びトリクロロプロパンからなる群より選ばれることを特徴とする請求項8記載の方法。
- 薬学的組成物であって、ジクロフェナクのセチルピリジニウム塩(I)の有効量及び少なくとも1種の薬学的に許容可能な不活性成分を含むことを特徴とする薬学的組成物。
- ジクロフェナクのセチルピリジニウム塩(I)が52〜55℃で融解することを特徴とする請求項10記載の薬学的組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000269A ITMI20030269A1 (it) | 2003-02-14 | 2003-02-14 | Sale di cetilpiridino di un agente antiinfiammatorio |
PCT/EP2004/001412 WO2004072017A1 (en) | 2003-02-14 | 2004-02-12 | Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006517565A true JP2006517565A (ja) | 2006-07-27 |
Family
ID=32866065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006501845A Ceased JP2006517565A (ja) | 2003-02-14 | 2004-02-12 | 抗炎症剤のセチルピリジニウム塩及びそれを含有する薬学的組成物 |
Country Status (16)
Country | Link |
---|---|
US (1) | US7250428B2 (ja) |
EP (1) | EP1592657A1 (ja) |
JP (1) | JP2006517565A (ja) |
KR (1) | KR20050101186A (ja) |
CN (1) | CN1318389C (ja) |
AR (1) | AR043171A1 (ja) |
AU (1) | AU2004212154A1 (ja) |
CA (1) | CA2511900A1 (ja) |
EA (1) | EA008003B1 (ja) |
GE (1) | GEP20064009B (ja) |
HK (1) | HK1080449A1 (ja) |
IL (1) | IL169312A (ja) |
IT (1) | ITMI20030269A1 (ja) |
MX (1) | MXPA05008589A (ja) |
PL (1) | PL376362A1 (ja) |
WO (1) | WO2004072017A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015190643A1 (ko) * | 2014-06-12 | 2015-12-17 | 한국생명공학연구원 | 부틸 피리디늄(butylpyridinium) 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
JP2018108954A (ja) * | 2016-12-28 | 2018-07-12 | 小林製薬株式会社 | 医薬組成物 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY129765A (en) * | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
US8349576B2 (en) * | 2009-07-15 | 2013-01-08 | University Of Medicine And Dentistry Of New Jersey | eEF2K assays for identifying compounds that inhibit eEF2K activity |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995033491A1 (en) * | 1994-06-06 | 1995-12-14 | Elmaleh David R | Biotin compounds for targetting tumors and sites of infection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT370721B (de) * | 1981-02-24 | 1983-04-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der |
IT1228242B (it) * | 1986-11-13 | 1991-06-05 | Ricerfarma Srl Milano | Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono |
IT1250636B (it) * | 1991-07-04 | 1995-04-21 | Ricerche Di Schiena Del Dr Mic | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. |
US5614223A (en) * | 1992-05-04 | 1997-03-25 | Digestive Care Inc. | Intraoral medicament-releasing device |
DE19856101A1 (de) * | 1998-12-04 | 2000-06-08 | Labtec Gmbh | Mundhöhlen-Matrixpflaster |
JP2000256186A (ja) * | 1999-03-05 | 2000-09-19 | Taisho Pharmaceut Co Ltd | 咽頭疾患用組成物 |
-
2003
- 2003-02-14 IT IT000269A patent/ITMI20030269A1/it unknown
-
2004
- 2004-02-12 WO PCT/EP2004/001412 patent/WO2004072017A1/en active Application Filing
- 2004-02-12 AU AU2004212154A patent/AU2004212154A1/en not_active Abandoned
- 2004-02-12 EA EA200501088A patent/EA008003B1/ru not_active IP Right Cessation
- 2004-02-12 CN CNB200480003068XA patent/CN1318389C/zh not_active Expired - Fee Related
- 2004-02-12 CA CA002511900A patent/CA2511900A1/en not_active Abandoned
- 2004-02-12 KR KR1020057013935A patent/KR20050101186A/ko not_active Application Discontinuation
- 2004-02-12 JP JP2006501845A patent/JP2006517565A/ja not_active Ceased
- 2004-02-12 EP EP04710394A patent/EP1592657A1/en not_active Withdrawn
- 2004-02-12 PL PL04376362A patent/PL376362A1/xx not_active Application Discontinuation
- 2004-02-12 MX MXPA05008589A patent/MXPA05008589A/es not_active Application Discontinuation
- 2004-02-12 US US10/544,224 patent/US7250428B2/en not_active Expired - Fee Related
- 2004-02-12 GE GEAP20048977A patent/GEP20064009B/en unknown
- 2004-02-13 AR ARP040100444A patent/AR043171A1/es not_active Application Discontinuation
-
2005
- 2005-06-21 IL IL169312A patent/IL169312A/en not_active IP Right Cessation
-
2006
- 2006-01-06 HK HK06100260.7A patent/HK1080449A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995033491A1 (en) * | 1994-06-06 | 1995-12-14 | Elmaleh David R | Biotin compounds for targetting tumors and sites of infection |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015190643A1 (ko) * | 2014-06-12 | 2015-12-17 | 한국생명공학연구원 | 부틸 피리디늄(butylpyridinium) 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
KR20150142536A (ko) * | 2014-06-12 | 2015-12-22 | 한국생명공학연구원 | 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
JP2017520622A (ja) * | 2014-06-12 | 2017-07-27 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | ブチルピロリジニウムまたはその誘導体を含む筋弛緩性疾患を予防または治療するための医薬組成物 |
EP3156055A4 (en) * | 2014-06-12 | 2018-01-17 | Korea Research Institute of Bioscience and Biotechnology | Pharmaceutical composition for preventing or treating muscular weakness-related diseases, containing butylpyridinium or derivative thereof |
US9949960B2 (en) | 2014-06-12 | 2018-04-24 | Korea Research Institute Of Bioscience And Biotechnology | Pharmaceutical composition for preventing or treating muscle weakness-related diseases, containing butylpyridinium or derivative thereof |
JP2018108954A (ja) * | 2016-12-28 | 2018-07-12 | 小林製薬株式会社 | 医薬組成物 |
JP7214331B2 (ja) | 2016-12-28 | 2023-01-30 | 小林製薬株式会社 | 医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
CN1318389C (zh) | 2007-05-30 |
EP1592657A1 (en) | 2005-11-09 |
US20060142353A1 (en) | 2006-06-29 |
PL376362A1 (en) | 2005-12-27 |
KR20050101186A (ko) | 2005-10-20 |
IL169312A (en) | 2010-05-17 |
EA008003B1 (ru) | 2007-02-27 |
MXPA05008589A (es) | 2005-11-04 |
GEP20064009B (en) | 2006-12-25 |
AR043171A1 (es) | 2005-07-20 |
EA200501088A1 (ru) | 2005-12-29 |
US7250428B2 (en) | 2007-07-31 |
HK1080449A1 (zh) | 2006-04-28 |
AU2004212154A1 (en) | 2004-08-26 |
CN1745061A (zh) | 2006-03-08 |
IL169312A0 (en) | 2007-07-04 |
WO2004072017A1 (en) | 2004-08-26 |
ITMI20030269A1 (it) | 2004-08-15 |
CA2511900A1 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4738984A (en) | Antirhinovirus agents | |
US4602099A (en) | Antirhinovirus agents | |
JPH0625301A (ja) | 置換インデニル酢酸のエステル及びアミド | |
CA3212170A1 (en) | Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases | |
IT9020944A1 (it) | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria | |
WO2006118329A1 (ja) | 安定な乳化組成物 | |
JP2013512275A (ja) | Hiv感染予防用ヒドロキシチロソール及び誘導体の局所使用 | |
JP4455760B2 (ja) | 特定の薬物の硝酸エステル及び硝酸塩 | |
IL169312A (en) | Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it | |
US8097646B2 (en) | Ophthalmic preparation containing menthyl ester of indomethacin | |
EP0521393B1 (en) | Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it | |
JPH0345055B2 (ja) | ||
ES2358564T3 (es) | Derivados de carbonilamino útiles para el tratamiento de una enfermedad inflamatoria intestinal. | |
EP0869117B1 (en) | Nimesulide choline salt, a process for the preparation thereof and pharmaceutical compositions containing it | |
JP2003512425A (ja) | 6−メトキシ−2−ナフチル酢酸プロドラッグ | |
WO2002085347A1 (fr) | Agent prophylactique/therapeutique pour les maladies inflammatoires des muqueuses de la cavite buccale et autres | |
JPS63101352A (ja) | 眼科治療用組成物 | |
JPS5942385A (ja) | キナゾリノン誘導体 | |
JP6596483B2 (ja) | パ−キンソン病治療用の新規高透過薬物及びその組成物 | |
JPS597115A (ja) | 消炎鎮痛外用剤 | |
EP0449722B1 (fr) | Nouveaux complexes de l'acide tiaprofénique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs dérivés | |
JP2003002828A (ja) | 口腔粘膜等における炎症性疾患の予防・治療剤 | |
FR2675506A1 (fr) | Sels ayant des activites anti-inflammatoire, antiseptique et detergente et compositions pharmaceutiques les contenant. | |
JPH03115219A (ja) | 経鼻投与製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070123 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070123 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070308 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070308 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100209 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100510 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100921 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101221 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110118 |
|
A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20110524 |